Staphylococcus aureus (MRSA), particularly in nosocomial infections, is a serious clinical problem worldwide. MRSA causes various infections, for example, skin and soft tissue infections, blood-borne infections, and pneumonia (Gemmell et al. 2006) . It is difficult to cure these infections because MRSA is multiple-drug resistant. MRSA strains emerge as the significant clinical problem around the world, and studies are moved ahead with the epidemiological analysis of typing of MRSA clones to mark a trend (Francois et al. 2004) .
Staphylococcal cassette chromosome mec (SCCmec) typing analyzes a mobile genetic element, SCCmec, which contains the mecA gene encoding methicillin resistance. Until now, SCCmec can be classified into 8 types according to size and composition. MRSA is characterized as SCCmec type IV, which has recently emerged within the community setting of some countries. Numerous community-associated (CA)-MRSA infections have been seen in young, healthy populations without predisposing risk factors (Bonnstetter et al. 2007) . As represented by the USA300 clone, CA-MRSA strains typically carry the Panton-Valentine leukocidin (lukS/F-PV) genes, which produce cytotoxins that cause leukocyte destruction and tissue necrosis (Genestier et al. 2005; Bonnstetter et al. 2007 ). These lukS/F-PV genes are also known to be involved in severe diseases, such as skin abscess formation, furunculosis and necrotizing pneumonia (Lina et al. 1999; Bonnstetter et al. 2007 ). In fact, there has been a particular increase in the number of reported lukS/F-PV-positive strains associated with severe necrotizing community-acquired pneumonia worldwide.
In contrast, the NY/Japan clone is characterized as SCCmec type II and carries enterotoxin C (sec) and toxic shock syndrome toxin 1 (tst) genes that have been circulating among hospitals in Japan. Moreover, two lukS/F-PVpositive MRSA strains were isolated in 2003 and 2004 from Japanese hospitals (Takizawa et al. 2005) , emphasizing the necessity to monitor lukS/F-PV-positive MRSA clones for preventing the spread of infection. SCCmec typing is useful for characterizing CA-MRSA clones. However, as previous methods are complicated, clinicians need a more rapid and simple detection system for CA-MRSA.
In this study, we therefore investigated genotypic characteristics of MRSA strains isolated in our hospital using SCCmec typing into four major types and analyzed various toxins based on antimicrobial susceptibility patterns to establish a convenient system for clinical application.
Materials and Methods

Clinical isolates
A total of 778 MRSA strains from our stock libraries isolated between January 2000 and December 2007 at the clinical microbiology laboratory of Nagasaki University Hospital were analyzed. Of these MRSA strains, 667 were isolated from pus (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) , 93 from sputum (2006) and 18 from blood (2006) . All strains were identified according to standard biochemical identification methods using standard culture media. Strains with an oxacillin MIC of ≥ 4 µ g/ml were considered to be MRSA strains. Of the strains collected each year, those isolates from the same patient were excluded. As negative controls for the mecA and nuclease (nuc) genes (for identification of S. aureus), 10 methicillin-sensitive S. aureus (MSSA) strains and 10 coagulase-negative staphylococci (CNS) strains were used. As the lukS/F-PV and vanA genes and the SCCmec type III elements are rare in Japan, the following strains were used as positive controls in this study: NIpvl (lukS/F-PV), BM4147 (vanA) and 85/2028 (SCCmec type III element). NIpv was kindly provided by Prof. Yamamoto (Niigata Univ.), BM4147 (vancomycin-resistant-enterococci) was kindly provided by Reiko Kariyama (Okayama Univ.), and 85/2028 was kindly provided by Prof. Hiramatsu (Juntendo Univ.).
After strains were cultured overnight on blood-agar plates (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan), bacterial DNA was extracted using Chelex (Bio-Rad Laboratories, Hercules, CA, USA), methanol, and boiling methods. Briefly, 200 µ l of 10% Chelex solution and 100 µ l of 250 U/ml achromopeptidase solution were placed in a 1.5-ml microcentrifuge tube and then mixed well with a colony of bacteria before incubation at 37-56°C for at least 15 min. The mixture was vortexed and incubated at 99°C for an additional 5 min and then chilled on ice for at least 1 min. After centrifugation at 12,000 rpm for 1 min, the supernatant was transferred to another 1.5-ml microcentrifuge tube and used for PCR amplification.
Susceptibility tests
MICs were determined by a broth microdilution assay according to Clinical and Laboratory Standard Institute reference methods. For susceptibility tests, we used custom-made frozen plates manufactured by Eiken Chemical Co. (Tokyo, Japan). Plates included nine antimicrobial agents: oxacillin (MPIPC; Sigma-Aldrich Japan Co., Tokyo, Japan), cefazolin (CEZ; Nichi-iko Pharmaceutical Co., Ltd., Toyama, Japan), cefmetazole (CMZ; Daiichi Sankyo Co., Ltd., Tokyo, Japan), cefpirome (CPR; Astellas Pharma Inc., Tokyo, Japan), imipenem (IPM; Banyu Pharmaceutical Co., Ltd., Tokyo, Japan), gentamicin (GM; Schering-Plough K.K., Osaka, Japan), minocyclin (MINO; Takeda Pharmaceutical Co. Ltd., Osaka, Japan), levofloxacin (LVFX; Daiichi Sankyo Co., Ltd., Tokyo, Japan), and vancomycin (VCM; Shionogi & Co., Ltd., Osaka, Japan). Inoculum was adjusted to yield a cell density of 5 × 10 5 CFU/ml. Plates were incubated for about 24 h at 36°C
and examined by visual observation. MIC was defined as the lowest concentration of antibiotic at which visible growth of the organism was completely inhibited.
Real-time PCR assay
PCR was performed using a LightCycler 480 (Roche Applied Science, Mannheim, Germany) to amplify a total of 10 genes in the same run. The PCR assay targeted SCCmec types I-IV, nuc, mecA, vanA, tst, sec, exfoliative toxin type b (etb) and lukS/F-PV (Table 1) . For SCCmec typing, three gene elements were used, SCCmec I, SCCmec II-III and SCCmec I-II-IV. SCCmec I was specific for SCCmec type I, SCCmec II-III for SCCmec types II and III, and SCCmec I-II-IV for SCCmec types I, II and IV. The four major SCCmec types were easily distinguished ( The original PCR primers and probes were designed based on published primers (Johnson et al. 1991 : Zhang et al. 2004 McClure et al. 2006) , and sequence specificity was confirmed against all available data for genes in the GenBank database. All primers and probes were purchased from Nihon Gene Research Laboratories Inc. (Miyagi, Japan). The target probes for SCCmec I-II-IV, mecA, vanA, tst and lukS/F-PV were labeled at the 5´-end with FAM, and target probes for SCCmec I, SCCmec II-III, nuc, etb and sec were labeled at the 5´-end with LCRED610. Both sets of probes were labeled at the 3´-end with Black Hole Quencher (BHQ). The only four types of the eight known SCCmec types were detected in this study because SCCmec type V-VIII are not spread in Japan.
Reactions were performed in a 20-µ l mixture of 0.5 µ M primers, 0.2 µ M TaqMan probes, 5 µ l DNA template and 2x LightCycler 480 Probes Master (Roche Applied Science, Mannheim, Germany). Two target genes were detected in each well using the multicolor detection system. Gene pairs are shown in Table 1 . Reaction conditions were 95°C for 10 min for activation of Taq polymerase, followed by 35 cycles of 10 s at 96°C (denaturation) and 50 s at 60°C (annealing and extension). Continuous fluorescence was monitored at 483-533 nm (FAM) and 550-610 nm (LCRED610). Fluorescence data were analyzed using LightCycler480R Software version 1.5.
Comparison of results with published PCR data
The multiplex PCR system for SCCmec typing established (Oliveira and de Lencastre 2002) was used for comparison of detection results. After isolates were characterized in our SCCmec typing system, 20 isolates of SCCmec type I, 30 isolates of SCCmec type II and 30 isolates of SCCmec type IV (total: 80 isolates) were chosen at random from the 776 MRSA isolates and used for comparison with published PCR data. Similarly, mecA, tst, sec and etb detection results were also compared with previous PCR data.
Results
Comparison of results with published PCR data
To evaluate our PCR system, we compared the detection results obtained in this study with those obtained from a previously published PCR method for SCCmec typing. These results, as well as those for detection of nuc, mecA, tst, sec and etb, were consistent with published data.
We used 10 MSSA and 10 CNS isolates as negative controls for mecA and nuc. The 10 MSSA isolates were negative for mecA, and the 10 CNS isolates were negative for nuc. Positive controls for lukS/F-PV, vanA and SCCmec type III element were positive using our PCR system.
Analysis of 778 MRSA isolates
The 667 MRSA isolated from pus were classified into (Fig.  1) .
Detection of virulence genes is shown in Table 3 . Sixteen isolates, all from pus, were etb positive. The etb gene was detected in 18.7% of type II and 81.3% of type IV isolates. No isolates were lukS/F-PV positive in this study.
A total of 87.5% of type II and 48.4% of type IV isolates had the tst and sec genes (Table 4) . Isolates from sputum (2006) possessing the sec and tst genes comprised 97.3% type II and 7.1% type IV, while those from pus comprised 88.5% type IV and 33.3% type II. Taken together, SCCmec type II isolates possessing sec and tst accounted for the majority of MRSA isolates from sputum, while MRSA isolates from pus had a wider variety of characteristics.
Susceptibility markers (MIC50 and MIC90) evaluated for each agent are shown in Table 5 . Overall, the MICs for cephalosporin, IPM and LVFX among type IV isolates were lower than those for type II. In particular, isolates showing an MIC of < 2 µ g/ml for IPM comprised 10.4% type II and 85.9% type IV. 
Discussion
We established a convenient system for SCCmec typing that is also capable of detecting pathogenic genes. We selected four pathogenic genes for this study. The first of these was etb, as it encodes exfoliative toxins (ETs), which are known to cause skin and soft tissue infections such as bullous impetigo, abscesses, furunculosis and staphylococcal scalded skin syndrome (SSSS). Much attention is now focused on etb because it is widespread in CA-MRSA in Japan (Noguchi et al. 2006) .
The second gene investigated in this study was tst, as it is present in S. aureus isolates, causing toxic shock syndrome in humans and animals. In Japan, tst is a commonly detected gene found in the NY/Japan clone, emphasizing the importance of identifying MRSA isolates with tst through Japanese epidemiologic studies.
The third gene investigated was sec. In addition to tst, sec is also present in the NY/Japan clone. Thus, to determine the type of clone, we must test for sec. Enterotoxins belong to a family of superantigens (Mehrotra et al. 2000) and are expressed by S. aureus, making it an important food-borne pathogen.
The final target gene was lukS/F-PV, as it encodes Panton-Valentine leukocidin, which has emerged in CA-MRSA strains. This exotoxin is involved in recurrent skin and soft tissue infections and lethal necrotizing pneumonia (Gillet et al. 2002) . Detection of lukS/F-PV is essential in epidemiologic studies of MRSA outbreaks worldwide.
Vancomycin-resistant S. aureus (VRSA) has also been reported in various parts of the world, and such reports are increasing in frequency (Tiwari and Sen 2006) . Detection of VRSA is important because infection by VRSA is difficult to treat. We therefore tested for the vanA gene using our PCR system.
The appearance of endemic CA-MRSA has recently been reported (Francois et al. 2004) . In contrast to hospitalassociated (HA)-MRSA, CA-MRSA is frequently isolated from healthy people. In addition, CA-MRSA tends to lead to serious and fatal outcomes. CA-MRSA isolates generally carry the SCCmec type IV element, which is much smaller than the SCCmec type I, II and III elements (Francois et al. 2004) . It is thought that the SCCmec type IV element is prone to insertion into the MSSA in the community setting.
In Japan, about 4% of MRSA clones are classified as SCCmec type IV Zaraket et al. 2007) . However, in our study, we detected 19.2% to be SCCmec type IV, mostly isolated from hospitalized patients. We also observed numerous cases of nosocomial infection. As it has been reported that CA-MRSA was brought into hospitals from the community (Zaraket et al. 2007 ), we believe that SCCmec type IV was also brought into and spread throughout our hospital. The transition of SCCmec types of MRSA from pus between 2000 and 2007 indicates that SCCmec type IV has become more prevalent over the past 8 years in Nagasaki, and it is likely to continue increasing.
Under the selective pressure caused by extensive antibiotic use, MRSA strains predominant in the early 1980s appear to have been replaced by those carrying the SCCmec type II element, which is associated with several resistance genes, in response to environmental changes . On the other hand, SCCmec type IV clones are more sensitive than SCCmec type II clones, as CA-MRSA has a lower chance of exposure to antibiotics. In fact, our study showed differences in MIC50 and MIC90 with several agents, including cephem antibiotic, LVFX, and especially IPM. As MRSA is sensitive to IPM, it is more likely to be SCCmec type IV, indicating that IPM MIC is useful for SCCmec typing. In contrast, none of the MRSA strains detected from 2000 to 2007 possessed vanA or showed a VCM MIC of > 8 µ g/ml.
In Japan, no VRSA has been reported. Recently detected HA-MRSA clones in Japan are considered to be the NY/Japan clone, which is one of the major MRSA clones worldwide. The NY/Japan clone is characterized by a sequence type 5, SCCmec type II element, and possessing the tst and sec genes (Zaraket et al. 2007 ). In the present study, we frequently detected MRSA clones both characterized as SCCmec type II and positive for tst and sec (70.1%). We assumed that these clones were the NY/Japan clones. However, 48.4% of SCCmec type IV MRSA isolates were also positive for tst and sec; of these, 33.3% were from pus in 2006 and 7.1% were from sputum (Table 5 ). In contrast, SCCmec type II isolates considered to be NY/Japan clones were detected more frequently in sputum than in pus.
A recent study reported that almost all etb-positive CA-MRSA strains isolated from outpatients with impetigo and SSSS carried SCCmec type IV elements (Noguchi et al. 2006) . In this study, 81.2% of etb-positive strains were SCCmec type II, indicating that, currently, HA-MRSA clones frequently carry etb.
Although lukS/F-PV was not detected in this study, lukS/F-PV-positive MRSA strains are known as high-pathogenic CA-MRSA. Few strains have been detected in Japan; however, it is feared that high-pathogenic CA-MRSA may take hold throughout the world.
Our results indicate changing trends in the common forms of MRSA (CA-MRSA and HA-MRSA). Clear differences were seen between SCCmec type and retention of toxins among the isolates over the 8-year period; however, these differences are becoming less obvious due to shortcomings in epidemiologic analysis approaches in Japan. Therefore, improving epidemiologic analysis is necessary not only in Japan but also worldwide. Identifying trends among MRSA strains may be one approach, as this will prevent the establishment of high-pathogenic CA-MRSA.
Our rapid and simple PCR system is useful for determining epidemiologic information and it can be applied to screening of unusual MRSA strains for the prevention of outbreaks of new MRSA clones.
